This "Change the Story" Technology Stock Zoomed 45% in Five Days – and Here's WhyBy William Patalon III, Executive Editor, Money Morning • May 20, 2016Start the conversationLeave a Reply Click here to cancel reply.Your email address will not be published. Required fields are marked *Name * Email * Website − 4 = 4 Comment Some HTML is OK Sign me up for the Money Morning newsletter William Patalon IIIWe've had some queries about TrovaGene Inc. (Nasdaq: TROV) after shares of our "Liquid Biopsy" recommendation rose five days in a row - an advance that took the shares up nearly 45% over those five trading sessions.And though we predicted this - and have devoted quite a bit of analysis to this stock of late - we're always glad to respond to inquiries... especially when it comes to a stock like this one that we believe offers a massive possible upside.This will be a relatively short update.And we'll start with the facts.This is premium content for Private Briefing subscribers only. As the executive editor of Money Morning, Bill Patalon has perfected a secret investment strategy that could help you put an extra $125K into your portfolio - this year. To date, Bill has used this strategy to pick 257 winning investments, including 192 double- and triple-digit peak gains. Once you see the secret, you'll immediately understand why it works so well.